Recruiting NCT06286267
AI-Assisted System for Accurate Diagnosis and Prognosis of Breast Phyllodes Tumors
Phyllodes Breast Tumor · Artificial Intelligence · Multiomics
Breast cancer
3,150 trials in this section
Recruiting NCT06281210
Vabb After Neoadjuvant Therapy to Avoid Surgery-pCR to Avoid Breast Surgery
Breast Cancer · Triple Negative Breast Cancer · HER2-positive Breast Cancer
Not yet recruiting NCT06195371
Impact of CASP3 Gene in Chemoresistance
Breast Cancer
Recruiting NCT06282796
Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy
Breast Cancer
Recruiting NCT05505357
Omission of Breast Surgery for Breast Cancer Patients With pCR on MRI and Vacuum-assisted Biopsy After NST (OPTIMIST)
Breast Cancer Invasive
Recruiting NCT06217185
The Efficacy and Safety of Pyrotinib, Trastuzumab Combined With Taxanes in the Treatment of Trastuzumab-treated HER2+ Advanced Breast Cancer (ABC).
HER2-positive Breast Cancer · Advanced Breast Cancer
Not yet recruiting NCT06270355
Stockholm Mammography Risk Stratified Trial
Breast Cancer
Recruiting NCT06278870
Disitamab Vedotin + Pyrotinib Versus THP in the First-line Treatment for HER2+ Advanced Breast Cancer Clinical Trial
HER2-positive Metastatic Breast Cancer · First-line Treatment
Recruiting NCT05999149
A Study of Camrelizumab Plus Chemotherapy in Combination With or Without Famitinib as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (BCTOP-T-N01)
TNBC - Triple-Negative Breast Cancer
Not yet recruiting NCT06268327
Adding Adjuvant Cisplatin and Gemicitabine Versus Capecitabine in Triple-negative Breast Cancer Patients in Non pCR After Neoadjuvant Standard Chemotherapy
Breast Cancer
Recruiting NCT06268652
Patient Derived Organoid-guided Personalized Treatment Versus Treatment of Physician's Choice in Breast Cancer
Breast Cancer · Refractory Breast Carcinoma
Not yet recruiting NCT06234150
Aerobic Dance During Chemotherapy in Breast Cancer Patients With Cognitive Impairment
Breast Neoplasms · Exercise Therapy · Chemotherapy-Related Cognitive Impairment
Recruiting NCT06266026
ThermoBreast - Non-contact Breast Cancer Imaging Using AI-enhanced Thermography.
Breast Cancer
Recruiting NCT06259162
LAG3 Expression in Triple Negative Breast Cancer
Triple Negative Breast Cancer · Immune Checkpoint Inhibitor
Recruiting NCT06259513
Omission of Axillary Surgery in Breast Cancer Patients
Breast Cancer · Sentinel Lymph Node · Breast Neoplasms
Recruiting NCT06254690
The Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase II Clinical Study
Breast Cancer
Not yet recruiting NCT06254066
Adebrelimab Combined With Fluzoparib in HRD-positive HR +/HER2- Advanced Breast Cancer
Female Breast Cancer Patients · Histopathologically Confirmed Advanced HR +/HER2-invasive Breast Cancer · HRD Positive Advanced Breast Cancer
Recruiting NCT02306096
Sweden Cancerome Analysis Network - Breast : Genomic Profiling of Breast Cancer
Breast Neoplasms
Recruiting NCT05949541
Efficacy of Everolimus Combined With First-line Endocrine Therapy for HR+/HER2- SNF1-subtype Advanced Breast Cancer
Breast Cancer · Advanced Breast Cancer
Recruiting NCT05891093
Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01)
Breast Cancer
Not yet recruiting NCT06245824
Trastuzumab Deruxtecan (T-DXd) With Pyrotinib in First-line HER2-positive Unresectable or Metastatic Breast Cancer Trial
Breast Cancer
Recruiting NCT05759572
Apatinib With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2- Advanced Breast Cancer
Breast Cancer Metastatic
Recruiting NCT02839863
Utrecht Cohort for Multiple Breast Cancer Intervention Studies and Long-term Evaluation - The UMBRELLA Cohort
Breast Cancer
Recruiting NCT05760378
Famitinib in Combination With Camrelizumab and TPC in The First-line Treatment of Immunomodulatory Locally Advanced or Metastatic TNBC.
Triple-Negative Breast Cancer
Recruiting NCT05759546
PARP Inhibitor With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast Cancer
Breast Cancer Metastatic
Recruiting NCT05159193
Neoadjuvant Treatment Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Sequential Docetaxel Plus Trastuzumab and Pertuzumab Versus Docetaxel Plus Carboplatin Combined With Trastuzumab and Pertuzumab in HER-2 Positive Breast Cancer
Breast Cancer
Recruiting NCT06235931
A Clinical Study of Darcilil Combined With AI Combined With Pyrrotinib in the Treatment of TPBC
Breast Neoplasms
Recruiting NCT06234137
A Prospective, Open, Multicenter Single-arm Clinical Studie of Docetaxel, Carboplatin Combined With Inetetamab and Pyrotinib in the Treatment of Local-advanced HER2-positive Breast Cancer
Breast Neoplasm Female
Recruiting NCT05888571
Pre-pectoral Breast Reconstruction With or Without Mesh
Prepectoral Breast Reconstruction · TiLOOP Mesh
Not yet recruiting NCT06229067
Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast Cancer
Breast Cancer · Triple Negative Breast Cancer
Recruiting NCT06169072
Sentinel Lymph Node Localisation With an Ultra-low Dose of Magtrace in Breast Cancer Patients
Breast Cancer · Sentinel Lymph Node
Not yet recruiting NCT06131632
Conserving Surgery in Inflammatory Breast Cancer After Neoadjuvant Chemotherapy
Inflammatory Breast Cancer
Recruiting NCT06214195
The Use of Shengmai San to Prevent Anthracycline Sequential Trastuzumab Therapy Related Cardiac Toxicity
Cardiotoxicity Induced by Drug Therapy for Breast Cancer
Recruiting NCT05954442
Everolimus With Investigator's Choice of Chemotherapy in Advanced Triple-Negative Breast Cancer (TNBC) With Luminal Androgen Receptor (LAR) Subtype
Triple Negative Breast Cancer · Metastatic Breast Cancer · Mutation
Not yet recruiting NCT05993559
Necessity of Post-mastectomy Radiotherapy After Neoadjuvant Chemotherapy and Mastectomy
Breast Cancer
Not yet recruiting NCT06202313
Study of Cadonilimab (AK104) Plus Eribulin vs. Eribulin Monotherapy for Recurrent or Metastatic Triple-negative Breast Cancer
Triple Negative Breast Cancer
Recruiting NCT06162559
Neoadjuvant Trastuzumab, Pertuzumab and Tucatinib Without Chemotherapy in HER2-positive Breast Cancer: the TRAIN-4 Study
Breast Cancer
Recruiting NCT06195202
Serum Estradiol (E2) Levels in Breast Cancer Patients During Endocrine Therapy by High Performance Liquid Chromatography-tandem Mass Spectrometry (LC-MS /MS)
Breast Cancer
Not yet recruiting NCT06193707
Intelligent Remote Intervention for High-risk Breast Cancer Populations
Ultrasonography · Breast Neoplasm Female · Breast Carcinoma
Not yet recruiting NCT06193122
Three-Dimensional Ultrasound and Spectroscopy as Early Indicators of Breast Cancer Response to Neoadjuvant Treatment
Breast Cancer
Recruiting NCT06165900
Stereotactic Radiotherapy Combined With Adebrelimab and TCb (Nab-paclitaxel + Carboplatin) in Neoadjuvant Treatment of TNBC
Stereotactic Radiotherapy · Immunotherapy · Breast Cancer
Recruiting NCT06185569
FREDO-ODX Study: FREnch Data on Outcomes in HR+/HER2- Early Breast Cancer Patients With oncotypeDX Recurrence Score-guided Therapy
Breast Cancer
Recruiting NCT04050228
Use of Quantitative Ultrasound to Guide Adaptive Chemotherapy Among Women With Breast Cancer
Breast Cancer
Not yet recruiting NCT06175078
Three-Dimensional Ultrasound Imaging and Spectroscopy for Characterizing Breast Masses
Breast Cancer · Breast Masses
Recruiting NCT06001086
A Phase II Clinical Study of Treatment With Disitamb Vedotin Plus Pyrotinib in HER2-positive Early Breast Cancer
Breast Cancer
Recruiting NCT04134780
Ultrasound Imaging and Spectroscopy as Early Indicators of Locally-Advanced Breast Cancer Response
Breast Cancer
Recruiting NCT04050423
Investigation of Ultrasound Imaging and Spectroscopy for Characterizing Breast Masses
Breast Cancer
Recruiting NCT04428528
Photoacoustic Imaging for Characterizing Breast Masses and Breast Tumor Response to Neoadjuvant Chemotherapy
Breast Cancer
Recruiting NCT00437879
Ultrasound Imaging, Spectroscopy and Ultrasound Imaging of Vascular Blood Flow as Early Indicators of Breast Cancer Response to Neoadjuvant Treatment.
Breast Cancer Invasive
Not yet recruiting NCT06154590
Anastrozole Adjuvant Trial - Study of Anastrozole Compared to NOLVADEX (Tamoxifen Citrate) for Adjuvant Treatment of Early Breast Cancer Clinical Studies), Adjunct Cytotoxic Chemotherapy and Malignant Joint Tumor
Metastatic Breast Cancer · Tumor · Muscle Neoplasms
Recruiting NCT04517266
Evaluating Omitting of Internal Mammary Irradiation Among Early Stage Intermediate Risk (N1) Breast Cancer
Breast Cancer
Recruiting NCT05978648
Trilaciclib in Patients With Early-Stage HR-negative Breast Cancer Receiving Adjuvant Chemotherapy
Breast Neoplasms
Recruiting NCT05987475
Prospective Observational Clinical Follow-up of Euromi Biosciences Pre-filled Silicone Gel Breast Implants
Breast Implant Rupture · Breast Implant; Complications
Recruiting NCT04902937
Association of Adjuvant Radiotherapy of Non-metastatic Breast Carcinoma With Immunomodulation and Circulating Tumor Cell Phenotype in Relation to Patient Age.
Tumor Cell, Circulating
Recruiting NCT05451784
Treatment of Advanced or Metastatic Triple-negative Breast Cancer With Adoptive Therapy of PD1+ TILS
Metastatic Triple-Negative Breast Carcinoma
Recruiting NCT06144346
Metastases Directed Therapy for Oligometastatic Breast Cancer
Breast Cancer · Metastatic Cancer · Metastatic Breast Cancer
Not yet recruiting NCT05477628
Nutrition Recommendation Intervention trialS in Children's Healthcare
Obesity, Childhood · Nutrition · Health Risk Behaviors
Not yet recruiting NCT06140576
The Efficacy and Safety of Lenvatinib Combined With Sindilimab and Nab-paclitaxel in the First-line Treatment for Recurrent and Metastatic Triple Negative Breast Cancer: a Phase Ib/IIa Clinical Trial.
Breast Neoplasms
Recruiting NCT06125080
The Efficacy and Safety of Utidelone Plus Tirelizumab and Bevacizumab for Advanced or Metastatic Triple-negative Breast Cancer (UTILIZABLE) ：Single-arm, Prospective, Open Clinical Study
TNBC - Triple-Negative Breast Cancer
Recruiting NCT06121570
Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer
Breast Neoplasms
Recruiting NCT06121557
Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer
Breast Neoplasms
Not yet recruiting NCT06113627
Lymphatic Response to Resistance Exercise in Breast Cancer Survivors
Breast Cancer Lymphedema · Survivorship · Lymphedema of Upper Limb
Not yet recruiting NCT06110845
CLinical Evaluation Of a comPuter Algorithm To Report BreAst cAncers (CLEOPATRAA)
Breast Cancer
Recruiting NCT06104085
99mTc-MY6349 SPECT/CT Imaging in Trop2-positive Triple-negative Breast Cancer
Breast Cancer
Recruiting NCT06090747
Improving Lifestyle Behavior by "Joven, Fuerte y Saludable" Multidisciplinary Program.
Breast Neoplasm
Not yet recruiting NCT05406661
Registry of Local Recurrences After Breast-conserving Surgery
Breast Cancer Recurrent
Recruiting NCT04925856
Immunomonitoring of Breast Cancer Patients During Systemic Treatment
Breast Cancer
Not yet recruiting NCT06085989
Nynnamm - Effects of Infant Directed Singing on Breastfeeding Difficulties
Breastfeeding
Not yet recruiting NCT06076772
Palbociclib Induced Neutropenia; Risk Factors and Treatment Outcome in Metastatic Breast Cancer Patients
Metastatic Breast Cancer
Recruiting NCT04687956
Primary Surgical Prevention of Breast Cancer-related Lymphedema
Lymphedema · Mastectomy · Breast Cancer
Recruiting NCT04741737
Repeat Sentinel Lymph Node Biopsy in Ipsilateral Breast Tumor Recurrence
Mastectomy
Recruiting NCT04817540
Phase II Trial of Anti-HER2 Treatment in HER2-enriched Early Breast Cancer Identified by PAM50 (HER2E-PAM, PAMILIA Study)
HER2 Enriched Subtype Breast Cancer, Herzuma, PAM50 Study
Recruiting NCT06073418
Dietary Habits, Nutritional Knowledge and Physical Activity Assessment in Early Stage Breast Cancer Patients
Breast Cancer
Recruiting NCT06001528
Serum and Tissue Metabolite-based Prediction of Sentinel Lymph Node Metastasis in Breast Cancer
Breast Cancer · Lymph Node Metastasis
Not yet recruiting NCT05860907
Clinical Study of Huaier Granules in Patients With Advanced Breast Cancer Without Visceral Metastasis
Breast Cancer Stage IV
Recruiting NCT06035016
Pyrotinib Plus Capecitabine for Adjuvant Treatment of HER2 Positive Early-stage Breast Cancer
HER2-positive Breast Cancer · Early-stage Breast Cancer
Not yet recruiting NCT06023277
A Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of ConvitVax in Metastatic Breast Cancer
Metastatic Breast Cancer
Not yet recruiting NCT06015113
Efficacy and Safety of Disitamab Vedotin Plus Pyrotinib or Naratinib in HER2-positive Breast Cancer Patients With Brain Metastasis
Breast Cancer
Recruiting NCT06000917
A Study of Neoadjuvant TCHpy（Pyrotinib ，Trastuzumab，Carboplatin and Paclitaxel）for ER+/HER2+ Breast Cancer
Breast Cancer · Neoadjuvant
Recruiting NCT05983107
Chidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast Cancer
HR+/HER2- Advanced Breast Cancer · Targeted Therapy
Not yet recruiting NCT05983094
Study of Utidelone Based Neoadjuvant Treatment on Early High-risk or Locally Advanced Breast Cancer
Breast Cancer · Neoadjuvant Therapy
Recruiting NCT05981014
Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer
Breast Neoplasms
Not yet recruiting NCT05980208
A Real-world Study of Inetetamab for First-line Treatment of MBC
Breast Cancer · Real-world Study
Recruiting NCT05981001
Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer
Breast Neoplasms
Not yet recruiting NCT05979220
Study of Dalpiciclib Combined With Letrozole in the Maintenance Treatment of HR Positive and HER2 Negative Metastatic Breast Cancer After First-line Chemotherapy
Breast Cancer
Recruiting NCT05976412
Regional Lymph Node Irradiation for High-risk pN0 Breast Cancer
Breast Cancer
Enrolling by invitation NCT05975437
Effectiveness of Personalized Surveillance and Aftercare for Breast Cancer
Breast Cancer · Breast Cancer Female · Survivorship
Recruiting NCT04722692
Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ
DCIS · Breast Cancer · Breast Neoplasms
Recruiting NCT05462366
Omics Sequencing of Specimen Derived From Mother-Infant-Pairs
Healthy · Breast-milk Collection · Feces
Not yet recruiting NCT05862610
The Study of Trilaciclib Combined With Chemotherapy On The Neoadjuvant Therapy of TNBC
Breast Neoplasm
Not yet recruiting NCT05953168
T-DXd in the First-Line Treatment of Locally Advanced or Metastatic TNBC-LAR HER2-low Patients
Triple-Negative Breast Cancer
Recruiting NCT05430399
Utidelone Versus Docetaxel in HER2-negative Locally Advanced or Metastatic Breast Cancer
Breast Neoplasms · Locally Advanced or Metastatic Breast Cancer
Recruiting NCT05928429
Effects of Cryotherapy on Taxane-Induced Neuropathy in Patients With Breast Cancer
CIPN - Chemotherapy-Induced Peripheral Neuropathy · Breast Cancer
Recruiting NCT05914831
Ultra-hypofractionated for Whole Breast Irradiation (WBI) Compared to Partial Breast Irradiation (PBI)
Breast Cancer Female
Recruiting NCT05883852
EC-THP Versus TCbHP in HER2-positive Lymph Node Positive Early Breast Cancer
HER2 Positive Early Breast Cancer
Recruiting NCT05916755
Predictive Biomarkers of Response to Checkpoint Inhibitors in Triple Negative Breast Cancer: a Multiomics Platform
Triple Negative Breast Cancer
Recruiting NCT05904964
Disitamab Vedotin (RC48) in Hormone Receptor Positive, HER2-low Metastatic Breast Cancer (the Rosy Trial)
HR Positive/HER2 Low Expression Metastatic Breast Cancer
Recruiting NCT05058183
Safe De-escalation of Chemotherapy for Stage 1 Breast Cancer
Breast Cancer
Recruiting NCT05871853
Get the Benefits From the Start. Improving Breastfeeding
Breastfeeding
Recruiting NCT04020575
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)
Metastatic Breast Cancer